ConductScience.org, home

Gene · 4209

MEF2D: myocyte enhancer factor 2D

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. MEF2D: myocyte enhancer factor 2D. Genes, record 4209. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/4209

On this page

Gene

Symbol
MEF2D
HGNC
Name
myocyte enhancer factor 2D
HGNC
NCBI Gene ID
4209
NCBI Gene
HGNC ID
HGNC:6997
HGNC
Ensembl
ENSG00000116604
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q14814Myocyte-specific enhancer factor 2D5212Ensembl, GeneID, HGNC

Source UniProt

Patents52

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1454531Q14814Espacenet
EP 4650780 A22025-11-192777Q14814Espacenet
EP 4640849 A22025-10-29345Q14814Espacenet
EP 4641201 A22025-10-292345Q14814Espacenet
JP 2025147176 A2025-10-0615278Q14814Espacenet
JP 2025519096 A2025-06-24345Q14814Espacenet
JP 2025517969 A2025-06-122345Q14814Espacenet
JP 2025517970 A2025-06-122777Q14814Espacenet
JP 2025513058 A2025-04-224Q14814Espacenet
JP 2025028160 A2025-02-2815278Q14814Espacenet

1 to 10 of 52

See all 52 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,131

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleMEF2D papersNewest fiscal year
P30CA021765Cancer Center Support Grant (CCSG)222025
R35CA197695Translating genomic discoveries to improved outcomes for high risk acute leukemia132025
P30CA008748Cancer Center Support Grant92025
U10CA180886COG NCTN Network Group Operations Center - Year 11 STAR Act MCI and PEC Supplement72025
U10CA180899Children's Oncology Group Statistics and Data Center72025
P30CA014520UW Comprehensive Cancer Center Support42025
P30CA016058Cancer Center Support Grant42025
U24CA196172ECOG-ACRIN Biospecimen Bank to Support NCTN42025
P01CA022443Molecular Biology and Genetics of Human Tumor Viruses32025
P30CA014599Cancer Center Support Grant32025

1 to 10 of 1,131Source NIH's project files

See all 1,131 nih grants

Papers1,497

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Clinical Relevance of Genomics Defined WHO5 Subtypes of Pediatric B-ALL in the Context of Measurable Residual Disease-Directed Risk-Based Therapy.JCO Glob Oncol202642691457PubTator, text miningPubMed
The Diverse Roles of the MEF2 Transcription Factor Family in Tumor Progression and Emerging Therapeutic Opportunities.Biomedicines202642652074PubTator, text miningPubMed
A synthetic hydrogel scaffold enhancing stem cell signatures in colorectal cancer cells.Biochem Biophys Res Commun202642537436PubTator, text miningPubMed
[Clinical analysis of 9 children of B-cell acute lymphoblastic leukemia with MEF2D gene rearrangement].Zhonghua Er Ke Za Zhi202642527140PubTator, text miningPubMed
The role of miRNA-32 in non-small cell lung cancer.Medicine (Baltimore)202642432883PubTator, text miningPubMed
Glioblastoma, IDH-wildtype, with a novel MEF2D-NTRK1 gene fusion: a case report.Front Oncol202642294267PubTator, text miningPubMed
Integrative multi-omics analysis identifies endocrine-disrupting chemical-related molecular mechanisms in migraine.J Headache Pain202642260332PubTator, text miningPubMed
Histone Deacetylase 7 protects against pathologic cardiac hypertrophy.J Mol Cell Cardiol202642250622PubTator, text miningPubMed
Overexpression of IGF2 Alters the Transcriptional Profile of Goose Skeletal Muscle Satellite Cells.Biomolecules202642072686PubTator, text miningPubMed
Genomic fusion breakpoints for DNA-based measurable residual disease monitoring in pediatric acute lymphoblastic leukemia.Leukemia202642014859PubTator, text miningPubMed

1 to 10 of 1,497

See all 1,497 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/4209

GET https://conductscience.org/api/genes/v1/4209/patents?page=2